![](https://i2.wp.com/hrnxt.com/wp-content/uploads/2020/08/Synthego_Logo.jpg?resize=200%2C112&ssl=1)
Synthego, the genome engineering company, announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Other investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego’s total private funding to more than $250 million. Also,…